{"id":"W2947055368","doi":"10.1200/jco.2019.37.15_suppl.10009","title":"Phase 1/1B trial to assess the activity of entrectinib in children and adolescents with recurrent or refractory solid tumors including central nervous system (CNS) tumors.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; ROS1; Response Evaluation Criteria in Solid Tumors; Internal medicine; Crizotinib; Refractory (planetary science); ALK inhibitor; Anaplastic lymphoma kinase; Oncology; Progressive disease; Cancer; Disease; Adenocarcinoma; Lung cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008225823,0.0006622438,0.001100594,0.00018252,0.0002104384,0.0004859614,0.0004365992,0.0008090275,0.003809051],"category_scores_gemma":[0.0005295824,0.0002426341,0.0005064746,0.0001743652,0.0003332438,0.0004893265,0.0002800596,0.002088149,0.0005393172],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007896315,"about_ca_system_score_gemma":0.0007920068,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007628149,"about_ca_topic_score_gemma":0.002988689,"domain_scores_codex":[0.9998343,0.00007189107,0.000009134914,0.00002860546,0.00001761904,0.00003839558],"domain_scores_gemma":[0.999693,0.00005516639,0.00008128825,0.00001413796,0.00001873244,0.0001376828],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6999509,0.02616783,0.03534675,0.002358354,0.002309566,0.001098437,0.0004583362,0.003978568,0.034012,0.0009328392,0.01731647,0.1760699],"study_design_scores_gemma":[0.6822653,0.2410503,0.0568391,0.0001970158,0.0007238297,0.0016799,0.00009898708,0.002325746,0.004327223,0.0003469514,0.01011794,0.0000276678],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9890261,0.004297374,0.0002614271,0.0006082768,0.0000750681,0.001369857,0.002118526,0.00006223733,0.002181049],"genre_scores_gemma":[0.9874731,0.002132281,0.001191981,0.0008116594,0.00007799063,0.001471173,0.004224846,0.00001447972,0.002602454],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003809051,"threshold_uncertainty_score":0.01274258,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.137663748049191,"score_gpt":0.4875379488064219,"score_spread":0.3498742007572309,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}